Maria Luisa Gasparri

Ospedale regionale di Lugano — Switzerland

Medicine · Health Sciences

34h-index3.7kcitations186works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endometrial and Cervical Cancer Treatments(50), Ovarian cancer diagnosis and treatment(44), Breast Cancer Treatment Studies(37), Uterine Myomas and Treatments(19), Cervical Cancer and HPV Research(18)

Publications182 total

Abstract PS5-08-12: Start of SerMa - EUBREAST 5 (Seroma of the Mammary Gland) study (NCT05899387)
Clinical Cancer Research·2026
Surgeon seniority and performance in breast-conserving surgery for non-palpable lesions: evidence from a multicenter study
The Breast·2026Open Access
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study
Journal of Clinical Oncology·2026
Radioguided Localisation Techniques for Non-Palpable Breast Lesions: An Umbrella Review
Journal of Clinical Medicine·2026Open Access
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
The Lancet Oncology·2025· 1 citedOpen Access
Efficacy of Intraoperative Widening of Surgical Resection Margins for Non-Palpable Breast Cancer: An Analysis of 771 Breast-Conserving Surgeries
Cancers·2025Open Access
Adherence to postpartum screening in women diagnosed with gestational diabetes: a retrospective single-centre experience in Switzerland
Swiss Medical Weekly·2025Open Access
Comparative effectiveness of preoperative localization techniques for non-palpable breast lesions: multicentre real-world study
BJS Open·2025Open Access
Breast Cancer Specialist Training across Europe: A European Union of Medical Specialists Multidisciplinary Joint Committee Breast Care Survey
Breast Care·2025Open Access
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
British journal of surgery·2025· 1 cited
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition
Nature Communications·2025· 1 citedOpen Access
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients – Results from the prospective AXSANA registry trial
European Journal of Cancer·2025· 6 cited
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
European Journal of Surgical Oncology·2025· 3 citedOpen Access
Abstract P3-12-16: MELODY: A prospective non-interventional multicenter cohort study to evaluate different imaging-guided methods for localization of malignant breast lesions (EUBREAST-4 / iBRA-NET, NCT 05559411)
Clinical Cancer Research·2025
Abstract P2-10-25: AXSANA: Status of the international prospective multicenter cohort study evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
Clinical Cancer Research·2025
Abstract P3-10-29: Start of SerMa – EUBREAST 5 (Seroma of the Mammary Gland) study (NCT05899387) - On the way to identify women at risk of developing seroma after mastectomy
Clinical Cancer Research·2025
Abstract PS6-06: Upstage of N-Stage by Diagnostic Axillary Lymph Node Dissection in Patients w/ Isolated Tumor Cells or Micrometastases in Sentinel/Target Lymph Node after Neoadjuvant Chemotherapy - Results from the Prospective Multicenter AXSANA / EUBREAST 3 Study
Clinical Cancer Research·2025· 3 cited
Consequences of lost axillary markers after neoadjuvant chemotherapy in breast cancer patients – data from the prospective international AXSANA cohort study (NCT04373655)
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2025
Status of the international prospective multicenter AXSANA study (NCT04373655) evaluating different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2025
Comparison of marking techniques for target lymph nodes in 2,596 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study (NCT04373655).
Journal of Clinical Oncology·2025· 1 cited
page 1 of 10Next →

Frequent Co-authors

Andrea Papadia(28), Michael D. Mueller(21), Pierluigi Benedetti Panici(19), Ilary Ruscito(12), Filippo Bellati(12), Ammad Ahmad Farooqı(8), Sara Imboden(7), Alessandro Buda(7), Oreste ­Gentilini(6), Violante Di Donato(6), Rosa Di Micco(5), Elena De Ponti(5), Giampaolo Di Martino(5), Cláudia Marchetti(4), Giorgio Bogani(4), Beatrice Bussi(4), Katayoun Taghavi(4), Marianna Nuti(4), Elena Ioana Braicu(3), Luigi Raio(3)